Marek Dobke

Dr. Marek Dobke

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2021 in Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
JCJ Sarah Crowley
J Sarah Crowley
ALAmy Liu
Amy Liu
MDMarek Dobke
Marek Dobke
This review discusses the most novel ideas and modalities being incorporated into facial rejuvenation. Recent innovative techniques include the use of regenerative stem cell techniques and regeneration supportive modalities such as nano-technology or gene therapies. This review aims to investigate approaches that are less well known and lacking established evidence in order to proactively study these techniques prior to them becoming popularized. These applications and relevant research were reviewed in the context of both surgical and non-surgical modalities in clinical practice. Future directions include the concept of “precision cosmetic medicine” utilizing gene editing and cellular therapies to tailor rejuvenation techniques based on each individual’s genetic make-up and therefore needs.

1 February 2020 in Regenerative Medicine
Verified
Journal Article
Open access
MDMarek Dobke
Marek Dobke
DPDale R Peterson
Dale R Peterson
RMRalph-Heiko Mattern
Ralph-Heiko Mattern
DADouglas M Arm
Douglas M Arm
WLWilliam W Li
William W Li
Aims: Profiling of microvascular tissue allows identification of components that stimulate wound healing. Here we study those elements for biological effect and establish clinical proof-of-concept ...

15 December 2020 in Annals of Plastic Surgery
Verified
Journal Article
Closed access
AHAdam Md Hauch
Adam Md Hauch
RMRyan BSc McKee
Ryan BSc McKee
WLWai-Yee Li
Wai-Yee Li
JCJiwon S. Crowley
Jiwon S. Crowley
SRSonia Ramamoorthy
Sonia Ramamoorthy
MDMarek Dobke
Marek Dobke
Introduction: Rectovaginal (RV) fistulas are notoriously difficult to treat. Various methods for repair exist, and refinements in techniques can lead to “successful” outcomes. Review of the literature demonstrates that outcomes studies are scarce and mostly limited to comments on closure rate. We have experienced “success” in our own series with 100% closure rate, regardless of fistula etiology and comorbidities (radiation, inflammation, etc). However, long-term outcomes, including various complications and quality of life changes, have previously been underreported. Methods: Critical analysis of various outcomes after fistula repair in 14 patients was performed. Patients were surveyed and interviewed with regard to problems before and after fistula repair to obtain objective data focusing on their experience and outcomes. Conclusions are based on physician assessment and patient surveys 1 year after fistula repair and at least 6 months after ostomy reversal and are discussed within the context of data from the literature. Results: Overall satisfaction rate after repairs was high. All patients would undergo attempt at repair again regardless of complications or functional changes (not present before repair). After repair, sexual dyspareunia affected 5 patients (36%); however, most abstained from sexual activity when their RV fistula became apparent. No patient admitted to dyspareunia before the development of their RV fistula. Anal sphincter and defecation function, as well as stool continence, were judged by surgeons and patients uniformly as adequate. However, 3 patients (21%) complained of intermittent problems with urination. A new/different type of pain affected 2 of 4 patients with Crohn disease. One of these patients subsequently developed a new postsphincteric RV fistula. Another patient noted new intermittent vaginal discharge after ostomy reversal, and magnetic resonance imaging suggested a residual fistula, which was not seen on follow-up sigmoidoscopy and “Blue Dye Test.” Conclusions: We previously reported on algorithms for repair and refinements in techniques for “successful” repair of RV fistulas with zero recurrence rate. Long-term follow-up indicates, however, that although the overall satisfaction rate after surgery is high, true “success,” defined as permanent fistula closure, is not necessarily problem free. Long-term morbidity and the management of other unique sequelae and problems are underreported.

1 August 2020 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
MDMarek Dobke
Marek Dobke
AHAdam Hauch
Adam Hauch
JCJiwon Crowley
Jiwon Crowley

1 February 2011 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
AHAli Hazrati
Ali Hazrati
AIAli Izadpanah
Ali Izadpanah
TZTeanoosh Zadeh
Teanoosh Zadeh
AGAmanda Gosman
Amanda Gosman
JCJames J. Chao
James J. Chao
MDMarek Dobke
Marek Dobke

7 October 2021 in Aesthetic Plastic Surgery
Verified
Journal Article
Open access
PDF file
GZGregorio Hernandez Zendejas
Gregorio Hernandez Zendejas
MDMarek Dobke
Marek Dobke
APAndrew Phelps
Andrew Phelps
GPGabriel Planas
Gabriel Planas
MSMarco Sanchez
Marco Sanchez
Background: A new technique in plastic surgery termed Osteogenesis Modulation is described. This technique uses a surgically implanted, battery-operated medical device to deliver customized electrical pulses to produce mandibular bone growth. This device was designed to be a temporary, nonpermanent implant. The purpose of this study was to review both the safety and efficacy of Osteogenesis Modulation.Methods: This study comprises two phases. Phase I involved experimental technology development and animal experiments. Phase II included technology development for clinical use and a clinical trial. In Phase II, four patients with a diagnosis of mandibular hypoplasia and microgenia underwent surgical implantation of the novel medical device over the chin bone. Once a satisfactory change of contour of mandibular bone was achieved, the devices were removed. In all patients, the devices were left in place for 12 months, then surgically removed under local anesthesia. Preoperative and long-term postoperative cephalometric controls were done.Results: In all patients, symmetrical mandibular bone growth was observed with good-to-excellent aesthetic results. The overall follow-up period was 39 months. Cephalometric controls taken 3 to 6 months after the device removal showed an average increase in mandible length of 5.26mm (range, 2.83–7.60mm)Conclusions: Preliminary clinical results suggest that Osteogenesis Modulation is a safe, minimally invasive, and effective alternative treatment for the correction of mandibular hypoplasia in selected cases.Level of Evidence IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authorswww.springer.com/00266.